Average Co-Inventor Count = 4.01
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Pfizer Corporation (15 from 4,455 patents)
2. Pharmacia & Upjohn Company (10 from 523 patents)
3. Pharmacia & Upjohn (1 from 20 patents)
26 patents:
1. 12312344 - N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors
2. 11708360 - N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors
3. 11655252 - Aminopyrimidinyl derivatives
4. 10975065 - N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors
5. 10815213 - Bruton's tyrosine kinase inhibitors
6. 10426135 - Methyl- and trifluromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof
7. 10385036 - Sulfonamide-substituted indole modulators of RORC2 and methods of use thereof
8. 10336748 - Methyoxy-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof
9. 10266513 - Bruton's tyrosine kinase inhibitors
10. 10227346 - Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use therof
11. 9920054 - Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof
12. 9670201 - Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof
13. 6903097 - Heterocycle carboxamides as antiviral agents
14. 6878705 - 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide antiviral agents
15. 6861438 - Antiviral agents